Skip to main content

Computational Notes on Fullerene Based System as HIV-1 Protease Inhibitors

Buy Article:

$107.14 + tax (Refund Policy)

According to the emerging biological applications of fullerene based systems, we try to utilize C60 after modifying its surface with polar group to enhance its solubility. Furthermore, we add hydroxymethylcarbonyl to form [C60-C2H4N-(2,4-XCOCH2OH)C6H4] where the X atom is O, S or Se. After that we perform geometry optimization and vibrational spectra using PM3 quantum mechanical method. Results show possible interaction between our structure and two aspartic acids units through hydrogen bonding. This indicates the ability of our structure to further interact with the two aspartic acids of the HIV-1 protease active site through the Hydroxymethylcarbonyl groups; accordingly, could be introduced as HIV-1 Protease Inhibitors.

Keywords: CHALCOGENE; FULLERENE; FULLEROPYRROLIDINE; HIV-1 PROTEASE; MOLECULAR MODELING

Document Type: Research Article

Publication date: 01 January 2010

More about this publication?
  • Journal of Computational and Theoretical Nanoscience is an international peer-reviewed journal with a wide-ranging coverage, consolidates research activities in all aspects of computational and theoretical nanoscience into a single reference source. This journal offers scientists and engineers peer-reviewed research papers in all aspects of computational and theoretical nanoscience and nanotechnology in chemistry, physics, materials science, engineering and biology to publish original full papers and timely state-of-the-art reviews and short communications encompassing the fundamental and applied research.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content